✦ LIBER ✦

High-dose cytosine arabinoside and amsacrine or mitoxantrone in relapsed and refractory acute myeloid leukaemia: a prospective randomized study

✍ Scribed by P. Martiat; J. M. Ghilain; A. Ferrant; C. Doyen; A. Delannoy; C. Chatelain; A. Bosly; J. L. Michaux; G. Sokal

Book ID: 114791327
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 327 KB
Volume: 45
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1990.tb00445.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clofarabine and high-dose cytosine arabi

Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia

✍ Eric Tse; Anskar Y. H. Leung; Joycelyn Sim; Harold K. K. Lee; Herman S. Y. Liu; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 98 KB

Clofarabine (40 mg/m^2^/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2 g/m^2^/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (__N__ = 4) and relapsed (__N__ = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myel

High-dose cytosine arabinoside and mitox

High-dose cytosine arabinoside and mitoxantrone: A highly effective regimen in refractory acute myeloid leukemia

✍ W. Hiddemann; H. Kreutzmann; K. Straif; W. D. Ludwig; R. Donhuijsen-Ant; E. Leng 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 134 KB

Treatment of refractory acute myeloid le

Treatment of refractory acute myeloid leukemia with high-dose cytosine arabinoside and mitoxantrone in combination

✍ W. Hiddemann; H. Kreutzmann; W.D. Ludwig; H.C. Aul; R. Donhuijsen-Ant; E. Lengfe 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 92 KB

High-dose versus intermediate-dose cytos

High-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone for the treatment of relapsed and refractory acute myeloid leukemia—preliminary clinical and pharmacological data of a randomized comparison

✍ Hiddemann, Wolfgang; Schleyer, Eberhard; Uhrmeister, Christa; Aul, Carlo H.; Mas 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 472 KB

Five-day 4′-(9-acridinylamino)methanesul

Five-day 4′-(9-acridinylamino)methanesulphon-m-anisidide and intermediate-dose cytosine arabinoside in high-risk relapsing or refractory acute myeloid leukemia

✍ Mathias Freund; Simone Giller; Fokke Hinrichs; Axel Baars; Johannes Meran; Alfre 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 435 KB

Salvage therapy with low-dose cytosine a

Salvage therapy with low-dose cytosine arabinoside in refractory or relapsed acute non-lymphocytic leukaemia: : A report on 25 patients

✍ M. Krogh Jensen; P. Johansen; J. Stentoft; M. Krogh Jensen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB